Literature DB >> 8213080

Neuroaxonal dystrophy in HTLV-1-associated myelopathy/tropical spastic paraparesis: neuropathologic and neuroimmunologic correlations.

E Wu1, D W Dickson, S Jacobson, C S Raine.   

Abstract

Detailed neuropathologic and immunohistologic analysis of a case of serologically and polymerase chain reaction-confirmed human immunodeficiency virus type I (HTLV-I)-associated myelopathy/tropical spastic paraparesis (HAM/TSP) is reported in a 73-year-old North American black woman. In addition to the usual neuropathologic features of HAM/TSP, including tractal degeneration of the spinal cord, leptomeningeal and perivascular fibrosis, perivascular demyelination and chronic inflammation, neuroaxonal spheroids were prominent in the spinal cord. Neuroaxonal dystrophy was characterized by neurofilamentous masses that were immunoreactive for phosphorylated neurofilament epitopes, but not ubiquitin. Neuroimmunologic analysis of the inflammatory reaction revealed a prevalence of CD8+ T cells and class I major histocompatibility molecules (MHC) (HLA-ABC and beta 2-microglobulin), but very few CD4+ T cells. Microglia were highly reactive for class II MHC (HLA-DR alpha) and this was attributed to activation, rather than CD4 interaction, since CD4 presence was minimal. Inflammatory cytokine immunoreactivity was also detected in glia. It is concluded that the cumulative effects of cytotoxic T cell (CD8) infiltration and the possible involvement of cytokines were responsible for the unusual degree of neuroaxonal dystrophy and vascular fibrosis, as well as the observed demyelination in this case.

Entities:  

Mesh:

Year:  1993        PMID: 8213080     DOI: 10.1007/bf00304136

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  34 in total

1.  HTLV-I-associated myelopathy: clinicopathologic correlation with localization of provirus to spinal cord.

Authors:  A I Bhigjee; C A Wiley; W Wachsman; T Amenomori; D Pirie; P L Bill; I Windsor
Journal:  Neurology       Date:  1991-12       Impact factor: 9.910

2.  Increased replication of HTLV-I in HTLV-I-associated myelopathy.

Authors:  M Yoshida; M Osame; H Kawai; M Toita; N Kuwasaki; Y Nishida; Y Hiraki; K Takahashi; K Nomura; S Sonoda
Journal:  Ann Neurol       Date:  1989-09       Impact factor: 10.422

3.  Immunological studies in tropical spastic paraparesis.

Authors:  S Jacobson; A Gupta; D Mattson; E Mingioli; D E McFarlin
Journal:  Ann Neurol       Date:  1990-02       Impact factor: 10.422

4.  Tropical spastic paraparesis: a model of virus-induced, cytotoxic T-cell-mediated demyelination?

Authors:  G R Moore; U Traugott; L C Scheinberg; C S Raine
Journal:  Ann Neurol       Date:  1989-10       Impact factor: 10.422

5.  Circulating CD8+ cytotoxic T lymphocytes specific for HTLV-I pX in patients with HTLV-I associated neurological disease.

Authors:  S Jacobson; H Shida; D E McFarlin; A S Fauci; S Koenig
Journal:  Nature       Date:  1990-11-15       Impact factor: 49.962

6.  Pathology of chronic myelopathy associated with HTLV-I infection (HAM/TSP).

Authors:  Y Iwasaki
Journal:  J Neurol Sci       Date:  1990-04       Impact factor: 3.181

7.  Presence of HTLV-I proviral DNA in central nervous system of patients with HTLV-I-associated myelopathy.

Authors:  J Kira; Y Itoyama; Y Koyanagi; J Tateishi; M Kishikawa; S Akizuki; I Kobayashi; N Toki; K Sueishi; H Sato
Journal:  Ann Neurol       Date:  1992-01       Impact factor: 10.422

8.  Spontaneous T cell proliferation and release of soluble interleukin-2 receptors in patients with HTLV-I-associated myelopathy.

Authors:  M Matsumoto; M Sugimoto; H Nakashima; F Imamura; O Kawano; E Uyama; K Takatsu; S Araki
Journal:  Am J Trop Med Hyg       Date:  1990-04       Impact factor: 2.345

9.  Immunological findings in neurological diseases associated with antibodies to HTLV-I: activated lymphocytes in tropical spastic paraparesis.

Authors:  S Jacobson; V Zaninovic; C Mora; P Rodgers-Johnson; W A Sheremata; C J Gibbs; C Gajdusek; D E McFarlin
Journal:  Ann Neurol       Date:  1988       Impact factor: 10.422

10.  Increases in helper inducer T cells and activated T cells in HTLV-I-associated myelopathy.

Authors:  Y Itoyama; J Kira; N Fujii; I Goto; N Yamamoto
Journal:  Ann Neurol       Date:  1989-08       Impact factor: 10.422

View more
  14 in total

Review 1.  Neuroimmunity of HTLV-I Infection.

Authors:  Eiji Matsuura; Yoshihisa Yamano; Steven Jacobson
Journal:  J Neuroimmune Pharmacol       Date:  2010-05-02       Impact factor: 4.147

2.  Presentation of human T cell leukemia virus type 1 (HTLV-1) Tax protein by dendritic cells: the underlying mechanism of HTLV-1-associated neuroinflammatory disease.

Authors:  Sharrón L Manuel; Todd D Schell; Edward Acheampong; Saifur Rahman; Zafar K Khan; Pooja Jain
Journal:  J Leukoc Biol       Date:  2009-08-05       Impact factor: 4.962

3.  Astrocyte-specific expression of human T-cell lymphotropic virus type 1 (HTLV-1) Tax: induction of tumor necrosis factor alpha and susceptibility to lysis by CD8+ HTLV-1-specific cytotoxic T cells.

Authors:  E Méndez; T Kawanishi; K Clemens; H Siomi; S S Soldan; P Calabresi; J Brady; S Jacobson
Journal:  J Virol       Date:  1997-12       Impact factor: 5.103

4.  Assessment of a new immunoassay for serological confirmation and discrimination of human T-cell lymphotropic virus infections.

Authors:  M Zrein; J Louwagie; H Boeykens; L Govers; G Hendrickx; F Bosman; E Sablon; C Demarquilly; M Boniface; E Saman
Journal:  Clin Diagn Lab Immunol       Date:  1998-01

5.  Human T-cell lymphotropic virus type 1-infected T lymphocytes impair catabolism and uptake of glutamate by astrocytes via Tax-1 and tumor necrosis factor alpha.

Authors:  R Szymocha; H Akaoka; M Dutuit; C Malcus; M Didier-Bazes; M F Belin; P Giraudon
Journal:  J Virol       Date:  2000-07       Impact factor: 5.103

6.  HTLV-I env protein acts as a major antigen in patients with HTLV-I-associated arthropathy.

Authors:  Tomohiro Kato; Hiroshi Asahara; Manae Suzuki Kurokawa; Koushi Fujisawa; Tomoko Hasunuma; Hajime Inoue; Masanao Tsuda; Shigeru Takahashi; Satoru Motokawa; Takayuki Sumida; Kusuki Nishioka
Journal:  Clin Rheumatol       Date:  2004-06-15       Impact factor: 2.980

7.  Analysis of the T-cell receptor repertoire of human T-cell leukemia virus type 1 (HTLV-1) Tax-specific CD8+ cytotoxic T lymphocytes from patients with HTLV-1-associated disease: evidence for oligoclonal expansion.

Authors:  U Utz; D Banks; S Jacobson; W E Biddison
Journal:  J Virol       Date:  1996-02       Impact factor: 5.103

8.  Direct evidence for a chronic CD8+-T-cell-mediated immune reaction to tax within the muscle of a human T-cell leukemia/lymphoma virus type 1-infected patient with sporadic inclusion body myositis.

Authors:  Simona Ozden; Madeleine Cochet; Jacqueline Mikol; Antonio Teixeira; Antoine Gessain; Claudine Pique
Journal:  J Virol       Date:  2004-10       Impact factor: 5.103

9.  Prion-like transmission of α-synuclein pathology in the context of an NFL null background.

Authors:  Nicola J Rutherford; Mieu Brooks; Cara J Riffe; Kimberly-Marie M Gorion; Jasie K Howard; Jess-Karan S Dhillon; Benoit I Giasson
Journal:  Neurosci Lett       Date:  2017-09-28       Impact factor: 3.046

10.  Induction of HLA class I and class II expression in human T-lymphotropic virus type I-infected neuroblastoma cells.

Authors:  T J Lehky; E P Cowan; L A Lampson; S Jacobson
Journal:  J Virol       Date:  1994-03       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.